克拉德里宾改善伊米基莫德诱导的小鼠牛皮形皮肤炎
Jingwen Xue1,2, Dan Shu1,2, Yi Zhao1,2
1Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, 102218, People's Republic of China.
Clinical, cosmetic and investigational dermatology
|February 24, 2025
概括
克拉德里宾有效地治疗小鼠的伊米基莫德诱导的牛皮,减少关键的炎症细胞和细胞因子. 这项研究表明,克拉德里宾.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮的发病因子涉及互白素 (IL) -23 / T-助手 (Th) 17轴.
- 治疗耐药性需要针对严重牛皮的新策略.
- 了解新的治疗机制至关重要.
研究的目的:
- 为了评估cladribine在imiquimod诱导的牛皮形皮炎的小鼠模型中的疗效.
- 调查克拉迪宾对皮肤免疫细胞群和细胞因子概况的影响.
- 评估克拉德里宾的持续治疗效果.
主要方法:
- 使用了一种因伊米基莫德 (IMQ) 诱导的牛皮形皮炎小鼠模型.
- 小鼠接受了不同剂量的克拉迪宾或甲铁酸盐治疗.
- 分析了皮肤病理,免疫细胞频率 (流动细胞计) 和血清细胞因子.
主要成果:
- 克拉德里宾显著改善了皮肤炎症状和皮肤病理,与甲醇相比.
- 克拉迪宾以剂量依赖的方式降低了Th17和Th1细胞频率以及相关的细胞因子.
- 高剂量的cladribine证明了对IMQ诱导的牛皮的持续有效性.
结论:
- 克拉德里宾有效地改善了小鼠的伊米基莫德诱导的牛皮形皮炎.
- 该药物表现出剂量依赖和持续的治疗效果.
- 克拉德里宾值得进一步研究,作为一种潜在的牛皮治疗方法.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
131
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
131
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107